Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive educational intervention vs usual care for anticoagulation control guided by SAMe-TT2R2 in anticoagulant-naive Thai atrial fibrillation patients
TCTR20180711003Phase 0Active, not recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised trial of warfarin in Atrial fibrillation (AFib) (2 arms), sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoint: Primary anticoagulation control outcome. Started Jan 2020; status: active, not recruiting.
02
Drugs
warfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20180711003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180711003.